Biofilms in Infection and Disease Control: A Healthcare Handbook outlines the scientific evidence and rationale for the prevention of infection, the role biofilms play in infection control, and the issues concerning their resistance to antimicrobials. This book provides practical guidance for healthcare and infection control professionals, as well as students, for preventing and controlling infection. Biofilms are the most common mode of bacterial growth in nature. Highly resistant to antibiotics and antimicrobials, biofilms are the source of more than 65 percent of health care associated infections (HCAI), which, according to the WHO, affect 1.4 million people annually. Biofilms are involved in 80 percent of all microbial infections in the body, including those associated with medical devices such as catheters, endotracheal tubes, joint prostheses, and heart valves. Biofilms are also the principle causes of infections of the middle-ear, dental caries, gingivitis, prostatitis and cystic fibrosis. Importantly, biofilms also significantly delay wound healing and reduce antimicrobial efficiency in at-risk or infected skin wounds.
Die Inhaltsangabe kann sich auf eine andere Ausgabe dieses Titels beziehen.
Professor Steven L. Percival holds a PhD in medical microbiology and biofilms, a BSc in Applied Biological Sciences, Postgraduate
Certificate in Education, diploma in Business Administration, an MSc in Public Health and an MSc in Medical and Molecular
Microbiology. He is also a fellow of the Institute of Biomedical Science and Institute of Biology. Early in his career, Steven held R&D positions for over 3 years at The British Textile Technology Group Plc, followed then by 6 years as a senior university lecturer in medical microbiology and later the positions of Chief Scientific Officer and Director of R and D at Aseptica, Inc., and senior clinical fellowships at the Centers for Disease Control,
Atlanta, and Leeds Teaching Hospitals Trust, Leeds, United Kingdom. More recently, Steven held senior R&D manager positions at Bristol Myers Squibb, ConvaTec, Advanced Medical Solutions PLC and also held an honorary Professorship of Microbiology at West Virginia University. In
2011, Steven joined ScapaHealthcare PLC as Vice President of Global Healthcare R&D and was awarded an honorary Professorship at The University of Liverpool, UK. He has written over 260 scientific publications and conference abstracts on water microbiology, biofilms, antimicrobials, and infection control and has authored or edited six textbooks on biofilms and microbiology and provided over 100 presentations on biofilms and public health worldwide.
Tracey has experience as both an author and peer reviewer and was the Infection Prevention Society (IPS) Editor from 2004-2008. She subsequently served as IPS Vice-President, and then President until 2012. She continues to participate in national and professional society initiatives and projects, and is particularly interested in professional development, change management and patient safety initiatives.
Outside work she enjoys running, loves the outdoors and participates in several Mountain Marathons each year.
Biofilms are the most common mode of bacterial growth in nature. Highly resistant to antibiotics and antimicrobials, biofilms are the source of more than 65 percent of Healthcare Associated Infections (HCAI), which, according to the WHO, affect 1.4 million people annually. Biofilms are involved in 80 percent of all microbial infections in the body, including those associated with medical devices such as catheters, endotracheal tubes, joint prestheses, and heart valves. Biofilms are also the principle causes of infections of the middle-ear, dental caries, gingivitis, prostatitis and cystic fibrosis. Importantly, biofilms also significantly delay wound healing and reduce antimicrobial efficiency in at-risk or infected skin wounds.
Biofilms in Infection and Disease Control: A Healthcare Handbook outlines the scientific evidence and rationale for the prevention of infection, the role biofilms play in infection control and the issues concerning their resistance to antimicrobials. This book provides practical guidance for healthcare and infection control professionals, as well as students, for preventing and controlling infection.
„Über diesen Titel“ kann sich auf eine andere Ausgabe dieses Titels beziehen.
EUR 13,24 für den Versand von USA nach Deutschland
Versandziele, Kosten & DauerEUR 10,18 für den Versand von Vereinigtes Königreich nach Deutschland
Versandziele, Kosten & DauerAnbieter: ThriftBooks-Atlanta, AUSTELL, GA, USA
Hardcover. Zustand: Very Good. No Jacket. May have limited writing in cover pages. Pages are unmarked. ~ ThriftBooks: Read More, Spend Less 2.05. Artikel-Nr. G0123970431I4N00
Anzahl: 1 verfügbar
Anbieter: Majestic Books, Hounslow, Vereinigtes Königreich
Zustand: New. pp. 400 16:B&W 7.5 x 9.25 in or 235 x 191 mm Case Laminate on White w/Gloss Lam. Artikel-Nr. 96131669
Anzahl: 3 verfügbar
Anbieter: moluna, Greven, Deutschland
Zustand: New. Outlines the scientific evidence and rationale for the prevention of infection, the role biofilms play in infection control, and the issues concerning their resistance to antimicrobials. This book provides practical guidance for healthcare and infection con. Artikel-Nr. 5891213
Anzahl: Mehr als 20 verfügbar
Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes Königreich
Zustand: New. In. Artikel-Nr. ria9780123970435_new
Anzahl: Mehr als 20 verfügbar